Division of Gynecologic Oncology

Faculty members in the Division of Gynecologic Oncology have collectively published more than 600 papers in peer-reviewed, high-quality medical journals. The division has received grants from the National Institutes of Health, including an R21 grant to study surrogate markers of tumor angiogenesis in cervical cancer, an R01 to study healthcare disparities and one of four prestigious Beau Biden Cancer Moonshot grants to study exceptional responders to therapy.

UC Irvine’s three-year Gynecologic Oncology Fellowship includes one year in the laboratory of a PhD mentor to conduct translational research on a wide array of projects relevant to the study of gynecologic cancers, including the tumor immune microenvironment, somatic mutations and biomarkers, and metabolomics. The robust basic science research program in gynecologic oncology makes discoveries to bridge the gap from the laboratory bench to the patient bedside.

During the two clinical years of the fellowship, the fellows work closely with the gynecologic oncology faculty and the cancer center research staff to identify eligible patients who may benefit from voluntary participation in our clinical trials for cancers of the ovary, endometrium, cervix and vulva. While most patients are referred from surrounding communities, it is not uncommon for patients to travel from anywhere in the United States to be screened for clinical trials at UC Irvine.

Integral to the gynecologic oncology research mission is our partnership with two nonprofit philanthropic organizations:

The Queen of Hearts Foundation was founded by three sisters—Kim, Cathy and Lori—whose mother, Anne, was diagnosed with ovarian cancer. The Queen of Hearts is dedicated to raising funds for research and early detection of ovarian cancer.

The Emerald Hope Foundation is a multigenerational volunteer group dedicated to raising funds to support cancer research.